In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy-Reference-Cited by-同舟云学术

In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy

Published:2016 Issue:20 Volume:8 Page:10706-10713
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Araújo F.,Shrestha N.,Gomes M. J.,Herranz-Blanco B.,Liu D.,Hirvonen J. J.,Granja P. L.,Santos H. A.,Sarmento B.

Funder

Seventh Framework Programme

Fundação para a Ciência e a Tecnologia

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2016/NR/C6NR00294C

Reference49 articles.

1. Protein therapeutics: a summary and pharmacological classification

2. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches

3. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles

4. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach

5. Nanotechnology for protein delivery: Overview and perspectives

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide GLP-1 receptor agonists: From injection to oral delivery strategies;Biochemical Pharmacology;2024-11

2. Porous Silicon Microparticles Enable Sustained Release of GLP‐1R Agonist Peptides for the Treatment of Type 2 Diabetes;Advanced Therapeutics;2024-08-10

3. Nanomaterials for diabetes: diagnosis, detection and delivery;Nanotechnology;2024-07-11

4. Sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) plus glucagon‐like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase‐4 inhibitor combination in treating obese mice metabolic dysfunction‐associated steatotic liver disease (MASLD);Fundamental & Clinical Pharmacology;2024-06-24

5. Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate;ACS Nanoscience Au;2024-04-05